Hydrocortisone 1% Cream for Contact Dermatitis on the Arm
For contact dermatitis on the arm in adults, prescribe hydrocortisone 1% cream, which is the standard FDA-approved concentration for over-the-counter use and represents an appropriate low-potency topical corticosteroid for this body location 1.
Rationale for 1% Concentration
The arm is a non-sensitive body area with relatively thick skin that tolerates low-potency corticosteroids well. Hydrocortisone 1% is classified as a low-potency (Class VII) topical corticosteroid and is the maximum strength available without prescription 1. This concentration provides adequate anti-inflammatory effect for contact dermatitis while minimizing the risk of local side effects such as skin atrophy and telangiectasia, which can occur even with hydrocortisone when used chronically 2.
Application Instructions
Apply twice daily initially: For acute contact dermatitis, apply the cream twice daily on the first day, then reduce to once daily from the second day onward 3. This approach is supported by pharmacokinetic data showing that plasma cortisol levels peak after the first two applications within 24 hours, after which the skin barrier begins to restore itself 3.
Duration: Use for no more than 7 days unless directed otherwise 1. If symptoms persist beyond this period or worsen, re-evaluation is necessary.
Avoid continuous use: Therapy should be intermittent rather than continuous to prevent complications 2.
Important Clinical Considerations
When 1% May Be Insufficient
If the contact dermatitis is severe or fails to respond to hydrocortisone 1% within several days, consider escalating to a mid-potency topical corticosteroid (Class IV-V) such as triamcinolone 0.1% or betamethasone valerate 0.1%. The arm can safely accommodate higher potency preparations if clinically indicated.
Pitfalls to Avoid
Don't use on broken skin or infected areas: Ensure there is no secondary infection requiring antimicrobial therapy first.
Concurrent irritant avoidance is essential: The British Journal of Dermatology guidelines emphasize that management of contact dermatitis principally involves protection from irritants—topical corticosteroids alone are insufficient without identifying and avoiding the causative agent 4.
Consider patch testing: If the dermatitis is recurrent or chronic, patch testing may be warranted to identify specific allergens, though systemic corticosteroids can cause false-negative results if used within the testing period 4.
Special Populations
For patients with widespread dermatitis or those who have used topical corticosteroids extensively, be aware that sensitization to hydrocortisone itself can occur, though this is uncommon 5, 6. If treatment failure occurs despite good compliance, consider corticosteroid contact allergy as a potential cause.